KRYSKrystal Biotech, Inc.

Nasdaq krystalbio.com


$ 159.96 $ -1.55 (-0.96 %)    

Friday, 31-May-2024 15:59:50 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 160.05
$ 163.00
$ 159.69 x 200
$ 160.20 x 100
$ 158.72 - $ 164.00
$ 93.95 - $ 189.97
187,581
na
4.69B
$ 0.93
$ 82.01
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-04-2020 03-31-2020 10-Q
18 03-10-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-05-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 03-12-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-200-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 pric...

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-200-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 pric...

 krystal-biotech-q1-2024-gaap-eps-003-beats-005-estimate-sales-45250m-miss-47419m-estimate

Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.0...

 hc-wainwright--co-reiterates-buy-on-krystal-biotech-maintains-200-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $200 pric...

 stifel-reiterates-buy-on-krystal-biotech-raises-price-target-to-204

Stifel analyst Dae Gon Ha reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $178 to $204.

 nio-reports-upbeat-earnings-joins-dave-v2x-riskified-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

 krystal-biotech-analysts-increase-their-forecasts-following-q4-results

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.

 citigroup-maintains-buy-on-krystal-biotech-raises-price-target-to-195

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $160...

 guggenheim-maintains-buy-on-krystal-biotech-raises-price-target-to-175

Guggenheim analyst Debjit Chattopadhyay maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from ...

 why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

 krystal-biotech-q4-eps-030-beats-039-estimate-sales-4214m-beat-2861m-estimate

Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.3...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION